JASON KIMATA to Antibodies, Viral
This is a "connection" page, showing publications JASON KIMATA has written about Antibodies, Viral.
Connection Strength
0.340
-
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Front Immunol. 2021; 12:693462.
Score: 0.115
-
Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment na?ve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors. PLoS One. 2012; 7(2):e31398.
Score: 0.059
-
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):174-185.
Score: 0.033
-
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):495-500.
Score: 0.031
-
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.
Score: 0.030
-
SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
Score: 0.028
-
The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol. 1993 Jun; 67(6):3134-41.
Score: 0.016
-
Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses. Virol J. 2008 Aug 04; 5:90.
Score: 0.012
-
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J Med Primatol. 2007 Aug; 36(4-5):254-65.
Score: 0.011
-
Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol. 1998 Jan; 72(1):209-17.
Score: 0.006